Product Name:

IKKb-NT


Product Number:

ab-nk076-5

Price:

Regular price
$89.00
Regular price
Sale price
$89.00

Download Product PDF

Target Full Name: Inhibitor of nuclear factor kappa B kinase beta subunit

Target Alias: I-kappa-B kinase 2; I-kappa-B-kinase beta; IkBKB; IKK2; IKKB; IKK-beta; NFKBIKB; IKBKINASE

Product Type Specific: Protein kinase pan-specific antibody

Antibody Code: NK076-6

Antibody Target Type: Pan-specific

Protein UniProt: O14920

Protein SigNET: O14920

Antibody Type: Polyclonal

Antibody Host Species: Rabbit

Antibody Immunogen Source: Human IKKb (IkBKB) sequence peptide Cat. No.: PE-01BDH90

Antibody Immunogen Sequence: MSWSPSLTTQTSGAWEMKEC

Antibody Immunogen Description: Corresponds to amino acid residues M1 to E19; N-terminus

Production Method: Corresponds to amino acid residues M1 to E19; N-terminus

Antibody Modification: Protein kinase pan-specific antibody

Antibody Concentration: 0.5 mg/ml

Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol

Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.

Product Use: Western blotting | Antibody microarray

Antibody Dilution Recommended: 2 µg/ml for immunoblotting

Antibody Species Reactivity: Human

Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 87-97 kDa.

Scientific Background: IKKb (IKBKB) is a protein-serine/threonine kinase of the Other group and IKK family. It functions in NF-kappa-B signalling and is activated by various indicators of cellular stress, including inflammatory cytokines, bacterial or viral products, and DNA damage. The activity of the kinase enables for NF-kappa-B to enter the nucleus and stimulate the transcription of genes involved in the immune response, control of cell growth, and cellular protection against apoptosis. IKKb may be a tumour requiring protein (TRP), since it displays extremely low rates of mutation in human cancers.